What do we need to know about allogeneic hematopoietic stem cell transplant survivors? - Wikidata - wikimedia - TriplyDB

What do we need to know about allogeneic hematopoietic stem cell transplant survivors?

What do we need to know about allogeneic hematopoietic stem cell transplant survivors?

http://www.wikidata.org/entity/Q38804386

about

Measurement of Hyperglycemia and Impact on Health Outcomes in People With Cancer: Challenges and Opportunities.Long-Term Survivorship after Hematopoietic Cell Transplantation: Roadmap for Research and Care.Palliative care during and following allogeneic hematopoietic stem cell transplantation.

P2860

Q38717505-E0E43AB9-0CEA-40E5-B004-E9C70E19DE48 Q38798042-91F218AF-4AF0-4C04-B932-97ED08A0FDE8 Q50173239-B7F46484-8F1B-4B38-8113-07FC64B73193

P2860

What do we need to know about allogeneic hematopoietic stem cell transplant survivors?

http://www.wikidata.org/entity/Q38804386

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

What do we need to know about allogeneic hematopoietic stem cell transplant survivors?

@en

type

label

What do we need to know about allogeneic hematopoietic stem cell transplant survivors?

@en

prefLabel

What do we need to know about allogeneic hematopoietic stem cell transplant survivors?

@en

P1433

Q38804386-0513D6D1-BFCA-4371-B539-138E387F26F4

P1476

Q38804386-C9547F8E-272D-4D21-BA7E-BFD0F355157F

P2093

Q38804386-32F628D8-91A6-41DE-BC2E-884AAEF8BE4D

Q38804386-46C8D936-740D-4A68-B59A-CE7D00E0A441

Q38804386-71C82958-91C5-402F-8CF0-D46636A720F6

Q38804386-B0898049-4F4F-4611-AFD5-47FD9C859A30

P2860

Q38804386-00586D86-EDF5-4363-8D09-AD09451BA23E

Q38804386-067ABCD1-7514-4D9E-9230-63212C88C063

Q38804386-0AC43A5A-A0ED-42ED-9B12-0A42419BBDFA

Q38804386-152A44A7-7D22-47B4-8412-294A527ABB6E

Q38804386-2BC5D48E-84D3-4639-8ABD-959ADC8E4211

Q38804386-4C531E2C-CD85-4187-8E17-9B99D6B9483A

Q38804386-4FBAC5FA-47DB-4A21-B6FC-D5224AA7E23E

Q38804386-5E086832-7EE5-4078-8BB8-46D8506B9A32

Q38804386-65CBF64C-0539-4DD8-B9DB-473AE770B0B2

Q38804386-6DF451D4-AA85-4C82-B0BC-F976E62B0228

P2888

Q38804386-0E8FACA8-EE35-4358-A335-DBB78F22618E

P304

Q38804386-60824727-90EA-4AB9-AB7B-B3CA4425E7CB

P31

Q38804386-F3435348-4E5D-4FD7-91B1-4A2D5B331265

P356

Q38804386-B8281924-EF10-4FA6-BA56-B0704B8C9170

P407

Q38804386-5A902706-55E1-402B-97DE-7A3AE94669F1

P433

Q38804386-39CDCC60-081C-4F4E-8DA6-DAD310F508D0

P478

Q38804386-C8251928-32EE-4838-8475-623AD7AB279A

P577

Q38804386-C9A59E8C-BD67-420E-A671-6585AC046392

P6179

Q38804386-73006C8D-DDEB-4525-9A5C-156DADB313B1

P698

Q38804386-C520BE4F-1AB3-4CC7-99B6-3C576E378744

P356

P1433

Bone Marrow Transplantation

P1476

What do we need to know about allogeneic hematopoietic stem cell transplant survivors?

@en

P2093

B N Savani

http://www.w3.org/2001/XMLSchema#string

C A Clark

http://www.w3.org/2001/XMLSchema#string

M Mohty

http://www.w3.org/2001/XMLSchema#string

M Savani

http://www.w3.org/2001/XMLSchema#string

P2860

Hematopoietic stem cell transplantation: a global perspective

Secondary solid cancer screening following hematopoietic cell transplantation

Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective

Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation.

How I treat late effects in adults after allogeneic stem cell transplantation.

Nonmalignant late effects after allogeneic stem cell transplantation.

Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.

Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants.

Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study.

P2888

P304

1025-1031

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2016.95

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1027573116

http://www.w3.org/2001/XMLSchema#string

P698

27064688

http://www.w3.org/2001/XMLSchema#string